Crystal Pharmatech

Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing three strategically located R&D centers in New Jersey (USA), Toronto (Canada), and Suzhou (China), we are powered by a skilled team of around 250 professionals. As a leader in both conventional and enabling formulation technologies, including amorphous solid dispersion, we take pride in our cGMP facilities, strictly adhering to the rigorous standards set...

Salt screening,polymorph screening,cocrystal screening,api characterization,api process optimization,api crystallization,chiral resolution,preformulation,amorphous solid dispersion,formulation characterization,crystallization development and optimization,formulation,gmp manufacturing,formulation development,and clinical and commercial manufacturing

Crystal pharmatech operates in the Pharmaceutical manufacturing industry.

Crystal pharmatech's revenue is 11m - 100m

Crystal pharmatech has 51 - 200 employees.